LYTIR

Insider · SEC Form 4 · Chief Technology Officer

Jay S. Stout

Filed with the SEC as Stout Jay S; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $2.0M of IMVT. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.0M in total.Jun: Insider sales $1.5MJul: Insider sales $248KOct: Insider sales $197KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. IMVTSold: Immunovant, Inc. Oct 21, 2026 2,595 shares filed Oct 23, 2026 198,937 shares held directly after, as filed filing $75K
  2. IMVTSold: Immunovant, Inc. Oct 7, 2026 3,809 shares filed Oct 9, 2026 2 transactions filing $122K
  3. IMVTSold: Immunovant, Inc. Jul 23, 2026 2,857 shares filed Jul 24, 2026 205,341 shares held directly after, as filed filing $111K
  4. IMVTSold: Immunovant, Inc. Jul 8, 2026 3,487 shares filed Jul 10, 2026 4 transactions filing $138K
  5. IMVTSold: Immunovant, Inc. Jun 26, 2026 40,000 shares filed Jun 26, 2026 2 transactions filing $1.5M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.